Approved comparison material connected to this topic.
3 total recordsSource comparisons are presented without a generated winner.
BPC-157 VEGF upregulation, angiogenesis promotion Inflammation → Proliferation 200–400 mcg/kg (animal models) 21–28 days at 4°C 62% greater collagen density at injury site (14 days post-injury, rat model) TB-5…
Dosing frequency Daily (once per day) Twice weekly (every 3–4 days) BPC-157 daily + TB-500 twice weekly Combined protocols are supported in animal models but lack human RCT data. Use with physician oversight S…
BPC-157 VEGF upregulation, growth hormone receptor modulation, nitric oxide pathway activation 2.3–4.5 mg/day subcutaneous (14–28 days) 72% increase in ligament-to-bone healing strength vs controls (J Orthop R…